Drug Safety Issue for Powerful Diabetes Drug

October 14, 2012

Type 2 diabetes is a pernicious, creeping, potentially fatal health condition. But while the disease is bad, for some patients the cure may have been even worse.

 

Actos (pioglitazone), a popular diabetes drug also sold under the names ActoplusMet and Duetact, may significantly increase health risks for some patients. According to several health care officials, prolonged Actos treatment has been positively linked to bladder cancer. In fact, patients undergoing long-term treatment are at particular risk.

 

Have the side effects associated with your loved one’s pioglitazone treatments overwhelmed the value of its benefits? Does your spouse or parent now suffer from bladder cancer? If the answers to these questions are yes, it may be time to learn about the legal side of these important medical realities. Talk to the attorneys at the law firm of Fears Nachawati today to learn what you need to know to make an informed decision about your family’s future. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to advise you!

More Blog Posts

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears | Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears | Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)